Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Capturing ctDNA from Unaltered Stationary and Flowing Plasma with dCas9.

ACS applied materials & interfaces - 1 Jun 2022

Downs Bradley M, Sukumar Saraswati

Abstract excerpt

Many studies have established that blood-based liquid biopsies can be used to detect cancer in its early stages. However, the limiting factor for early cancer detection is the volume of blood required to capture the small amount of circulating tumor DNA (ctDNA). An apheresis machine is a device that can draw whole blood, separate the blood components, and infuse the blood components back into the individual. This...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Cell-Free Nucleic Acids
Share to Circulating Tumor DNA

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Neoplasms

Share to Proto-Oncogene Proteins B-raf

Source

Identifiers

PMID: 35603357
DOI: 10.1021/acsami.2c03186

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Capturing ctDNA from Unaltered Stationary and Flowing Plasma with dCas9.PMID 35603357Read ↗

Increasing the Capture Rate of Circulating Tumor DNA in Unaltered Plasma Using Passive Microfluidic Mixer Flow Cells.Semantic proximity Read ↗

A hitchhiker’s guide to cell-free DNA biologySemantic proximity Read ↗

Whole genome amplification of cell-free DNA enables detection of circulating tumor DNA mutations from fingerstick capillary bloodSemantic proximity Read ↗

Effects of Collection and Processing Procedures on Plasma Circulating Cell-Free DNA from Cancer Patients.Semantic proximity Read ↗

Performance of Streck cfDNA Blood Collection Tubes for Liquid Biopsy Testing.Semantic proximity Read ↗

Single-nucleotide variant profiling in liquid biopsy with RECO-Cas.Semantic proximity Read ↗

Fully automated, on-site isolation of cfDNA from whole blood for cancer therapy monitoring.Semantic proximity Read ↗

Quasi-digital PCR: Enrichment and quantification of rare DNA variants.Semantic proximity Read ↗

CRISPR/dCas9-Mediated Specific Molecular Assembly Facilitates Genotyping of Mutant Circulating Tumor DNA.Semantic proximity Read ↗

Solid-State Nanopore Sizing for cfDNA Sample Quality Control in Point-of-Need SequencingSemantic proximity Read ↗

Priming agents transiently reduce the clearance of cell-free DNA to improve liquid biopsies.Semantic proximity Read ↗

Selective amplification of rare mutations using locked nucleic acid oligonucleotides that competitively inhibit primer binding to wild-type DNA.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.